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Han ChineseCopy number variation (CNV) is a form of DNA sequence variation in the human genome. CNVs can affect
expression of nearby and distant genes, and some of them might cause certain phenotypic differences. CNVs
vary slightly in location and frequency among different populations. Because currently-available CNV
information from Asian population was limited to fewer small-scale studies with only dozens of subjects, a
high-resolution CNV survey was conducted using a large number of Han Chinese in this study. The Illumina
HumanMap550K single-nucleotide polymorphism array was used to identify CNVs from 813 unrelated Han
Chinese residing in Taiwan. A total of 365 CNV regions were identiﬁed in this population, and the average size
of the CNV regions was 235 kb (covering a total of 2.86% of the human genome), and 67 (18.4%) were newly-
discovered CNV regions. Two hundred and seventy-nine CNV regions (76%) were veriﬁed from 304
randomly-selected samples by Affymetrix 500K GeneChip and qPCR experiments. These regions contain 1029
genes, some of which are associated with diseases. Consistent with previous studies, most CNVs were rare
structural variations in the human genome, and only 64 regions (17.5%) had a CNV allele frequency greater
than 1%. Our discovery of 67 new CNV regions indicates that previous CNV coverage of the human genome is
incomplete and there is diversity among different ethnic populations. The comprehensive knowledge of
CNVs in the human genome is very important and useful in further genetic studies.© 2009 Elsevier Inc. All rights reserved.Introduction
Among DNA sequence variations in the human genome, copy
number variation (CNV) directly contributes to gene expression
changes through gene dosage effects; the distribution of CNVs is now
considered to be wider than previously thought [1–6]. Copy number-
variable regions (CNVRs) have been estimated to cover 18% of the
human genome [7], and some copy number (CN)-variable genes are
associated with human diseases such as schizophrenia and autism
[8,9]. The distribution of CNVs is somewhat different in different
genetic backgrounds, and population-speciﬁc CNVs might account for
the divergence of some physiological traits and disease prevalence
among populations [10].
Comparative genomic hybridization and single-nucleotide poly-
morphism (SNP) arrays are high-resolution tools for detecting subtle
CN alterations at the genome scale [11–13]. Although the next-
generation sequencing systems, e.g., Illumina/Solexa and Applied
Biosystems/SOLiD, can achieve single base-pair resolution [14], they
are still too expensive to be applied to large-scale CNV survey at the
genome-wide scales. The Illumina BeadChip and Affymetrix GeneChipnn).
ll rights reserved.SNP arrays are frequently used for genotyping and can be used to
effectively infer allelic CN.
Due to the lack of population-speciﬁc CNV information from Han
Chinese population, Lin et al. (2008) used Affymetrix 100K GeneChip
SNP array to identify 230 CNVRs from 300 unrelated individuals, and
42% CNVRs were novel, indicating that there is much diversity in CNV
distribution among different populations [15]. Due to major technical
progressions, we further extended the study to detect genome-wide
CNVRs using a larger sample size (813 normal unrelated individuals)
at ﬁve-fold resolution. Illumina 550K BeadChip was chosen as our
primary data collection tool, and Affymetrix 500K GeneChip was used
to validate some of the data from the Illumina array. The mean
intermarker distances of the Illumina 550K BeadChip and the
Affymetrix 500K GeneChip are 5.24 and 5.87 kb, respectively. We
used the PennCNV program to analyze the data from the Illumina
550K BeadChip, because this program, when analyzing data from this
SNP array, is an effective algorithm for detecting CN-altered regions
with a low false-positive rate (FPR) and false-negative rate (FNR) [13].
The combined FPR and FNR has been no more than 7.7% in previous
studies [3]. Only DNA segments detected as CN losses and/or gains in
at least two individuals were regarded as true CNVRs. A total of 365
CNVRs were identiﬁed in the sample population, and 298 (81.6%)
were previously reported in the Database of Genomic Variants. These
newly identiﬁed as well as previously reported CNVRs in the human
242 C.-H. Lin et al. / Genomics 94 (2009) 241–246genome should be seriously taken into consideration when further
genetic studies are to be carried out.
Results
Detection of CNVs in Han Chinese in Taiwan
Data from the Illumina 550K BeadChip of 813 unrelated Taiwanese
were analyzed to identify CNVRs of the Han Chinese population in
Taiwan. DNA samples of all individuals were extracted fromperipheral
blood to exclude the possibility of chromosomal abnormalities arising
from cell culturing. Using a stringent criterion (DNA regions
encompassing more than 10 SNPs), 4452 reliable CN-altered events
(1025 non-redundant genomic regions which are deﬁned as any
overlap of CNVs) were found in the 813 individuals. To conﬁrm these
results, a random sample of 304 of the 813 individuals was genotyped
using the Affymetrix 500K GeneChip, and the data were analyzed
using the copy number inferring tool (CNIT) program [16]. All CN-
altered events (encompassing more than 10 SNPs) predicted by the
PennCNV analysis of the Illumina 550K BeadChip data were also
identiﬁed by the Affymetrix 500KGeneChip experiments. Examples of
a one-copy loss and a one-copy gain of genomic segments are shown
in Fig. 1. In addition to the CNIT program, the copy number analysis
tool (CNAT) 4.0 program was also used with the Affymetrix 500K
GeneChip data to infer CN-altered regions. We obtained the same
results in both cases, thereby showing that the CNVs are algorithm-
independent and are detectable with either platform.Fig. 1. A one-copy loss and a one-copy gain among 813 normal unrelated Taiwanese indiv
HumanHap550-Duo BeadChip showing a one-copy loss (214 kb) on chromosome 1 (A) and a
of each SNP probe, and the colored shadow boxes represent DNA segments having the samBased on the CNV analysis of Illumina 550K BeadChip, only 365 of
the 1025 non-redundant genomic regions were found to be CN
variable in at least two individuals, and were regarded as CNVRs in
this study (Supplementary Table 1). If a CNVR in this study overlapped
at least 1 bp of known CNVs, it is regarded as a reported region. The
majority of the CNVRs (298; 81.6%) had been reported in the Database
of Genomic Variants (March 2009, v7). In order to validate CNVRs,
especially those common CNV loci, identiﬁed from Illumina 550K
BeadChip, 304 randomly-selected individuals were genotyped by
using Affymetrix 500K GeneChip. Two hundred and seventy-nine
(76%) of the 365 CNVRs reported in the study were detected from
these 304 samples. We believed these CNVRs are true-positives since
the 279 regions were independently conﬁrmed by Affymetrix array.
The average CNV coverage per genome is 497 kb, the average number
of CNV per sample is 4.6, and 90% of the normal individuals from the
general population had ten or fewer CNVs (Fig. 2A).
Of the 365 CNVRs, 133 (36%) had CN-loss alleles, 142 (39%) had
CN-gain alleles, and 90 (25%) were comprised of alleles having both
CN losses and gains. These CNVRs ranged from 9.6 kb to 2.8 Mb
(mean=235 kb, Fig. 2B) and covered a total of 2.86% of the human
genome. These CNVRs were widely dispersed throughout the ge-
nome, and only 64 of 365 CNVRs had a CNV allele frequency greater
than 1% (Fig. 3), indicating that most CNVRs are rare structural
variants in the human genome. One hundred and thirty-nine CNVRs
(38%) were associated with segmental duplications (SDs), which
induce non-allelic homologous recombination and produce structural
variants [4].iduals. Copy number variation data from the Affymetrix 500K GeneChip and Illumina
one-copy gain (88 kb) on chromosome 2 (B). Each dot represents the log2 intensity ratio
e copy number.
Fig. 2. Copy number variation (CNV) summary in this study. (A) The distribution of CNV
frequencies in the Han Chinese population. Ninety percent of the normal individuals
from the general population had ten or fewer CNVs. (B) The occurrence of copy number-
variable regions (CNVRs) among the Han Chinese population. The sizes of most CNVRs
(74%) were smaller than 250 kb. Green and blue colors indicated known and novel
CNVRs, respectively.
Fig. 4. The phylogenetic tree based on the copy number variation (CNV) information.
Nei's distance between any two populations was calculated based on the allele
frequency of 19 CNV regions. Phylogenetic tree was constructed based on the neighbor-
joining method with 10,000 bootstrap replications. The Taiwan and China are closer to
each other relative to the other populations.
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common ancestry with the HapMap CHB and JPT populations;
therefore, our results were compared with the CNV information of
45 HapMap CHB and 45 JPT unrelated individuals acquired from
Redon et al.'s study [4], in which Affymetrix 500K GeneChip and CGHFig. 3. The copy number variation (CNV) map of Han Chinese population. Three
hundred and sixty-ﬁve CNV regions identiﬁed from 813 unrelated individuals using the
Illumina 550K single-nucleotide polymorphism array. Different colors present different
copy number state, and higher bar indicates higher CNV allele frequencies (N0.05).array were both used to detect CNVs from cell line DNA and 192 and
182 CNV regions were reported in these CHB and JPT samples,
respectively. Among these regions, 182 (94.8%) CHB and 178 (97.8%)
JPT CNVRs cover at least 10 SNP probes on Illumina 550K BeadChip.
Thirty-two percent of the CHB CNVRs and 31% of the JPT CNVRs were
found in our Taiwanese population. In addition, Jakobsson et al. used
Illumina 550K BeadChip to detect CNVs from 29 multi-ethnic
populations [3]. CNVs identiﬁed from eight populations which contain
more than 30 individuals from Jakobsson et al.'s study and our CNVs
were integrated to construct phylogenetic tree based on their
frequency data (Fig. 4). As we expected, the Taiwan and China
populations are closer to each other relative to the other populations.
Genes and miRNAs within the CNVRs
There are 1029 genes located within 245 of the 365 CNVRs
(Supplementary Table 2), and 80 of these genes (7.8%) have not
previously been reported to be CN variable. Of the 1029 genes, 336 and
180 had only CN gains and losses, respectively. The Gene Ontology
(GO) databasewas used to annotate 1029 geneswhich were disrupted
by CNVs in the Han Chinese population. As shown in Fig. 5, the GO
terms were distributed as the following, 29.1% protein binding, 12.5%
metal ion binding, 12.0% zinc ion binding, 10.0% nucleotide binding,Fig. 5. Gene Ontology (GO) summary of copy number (CN)-variable genes. The GO
database was used to annotate the 1029 genes which were disrupted by CNVs in the
Han Chinese population.
Table 1
Cancer-related genes in the copy number-variable regions (CNVRs).
CNVR ID Gene symbola Chromosome band Variant type No. of observationsb Tumor types Cancer molecular geneticsc
4 PRDM16 1p36.23–p33 Gain 1 Myelodysplastic syndrome, acute myelogenous leukaemia D
5 RPL22 3q26 Gain 2 Acute myelogenous leukaemia, chronic myeloid leukaemia D
29 ALK 2p23 Loss 5 Anaplastic large-cell lymphoma,
non-small-cell lung cancer, neuroblastoma
D
37 TTL 2q13 Gain and Loss 2 Acute lymphoblastic leukaemia D
127 ETV1 7p22 Gain 1 Ewing sarcoma, prostate D
165 RECQL4 8q24.3 Gain and Loss 1 Osteosarcoma R
180 SET 9q34 Gain 2 Acute myelogenous leukaemia D
187 NOTCH1 9q34.3 Gain and Loss 46 T-cell acute lymphoblastic leukaemia D
206 HRAS 11p15.5 Gain and Loss 3 Infrequent sarcomas, rare other types D
218 MEN1 11q13 Loss 2 Parathyroid tumors R
261 AKT1 14q32.32 Gain 69 Breast, colorectal, ovarian, non-small-cell lung cancer D
276 TSC2 16p13.3 Gain 9 Hamartoma R
290 CBFA2T3 16q24 Gain and Loss 8 Acute myelogenous leukaemia D
297 MLLT6 17q21 Loss 2 Acute leukaemia D
314 FSTL3 19p13 Gain and Loss 13 B-cell lymphoblastic leukaemia D
STK11 19p13.3 Gain and Loss 17 Non-small-cell lung cancer, pancreatic R
319 SH3GL1 19p13.3 Loss 1 Acute leukaemia D
323 BRD4 19p13.1 Loss 1 Lethal midline carcinoma of young people D
332 ERCC2 19q13.2–q13.3 Loss 2 Melanoma R
334 ZNF331 19q13.3–q13.4 Gain and Loss 1 Follicular thyroid adenoma D
355 CLTCL1 22q11.21 Gain and Loss 1 Anaplastic large-cell lymphoma D
All of these CNVRs had been reported in the Database of Genomic Variants.
a CNVR-overlapping cancer genes were determined based on the database of the Cancer Genome Project (http://www.sanger.ac.uk/genetics/CGP/).
b Total number of individuals with copy number changes observed for each gene.
c D and R represent dominant and recessive inheritance, respectively.
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others (16%). For example, CACNA1H (calcium channel, voltage-
dependent, T type, alpha 1H subunit) and KCNT1 (potassium channel,
subfamily T, member 1) genes were found to have variable CN in
general population, and they were validated by using quantitative PCR
(qPCR) experiments. Speciﬁcally, some GO categories, including zinc
ion binding, magnesium ion binding and olfactory receptor activity
showed more than 10-fold enrichment in CNV regions, but genes
involving in signal transducer activity, nucleic acid binding and
transporter activity were impoverished (Supplementary Table 3).
Ninety genes that have variable CNs in these samples are disease
related (Supplementary Table 4). For example, ﬁve individuals had a
one-copy deletion of the gene for the nicotinic cholinergic receptor β1
subunit (CHRNB1), whose deﬁciency causes myasthenic syndrome
[17]. Twenty-one cancer-related genes were found to locate in these
CNVRs (Table 1), and all of which have previously been reported in the
Database of Genomic Variants [18]. Two of the 813 individuals carried
a one-copy deletion of the multiple endocrine neoplasia I (MEN1)
gene located at chromosome 11q13, which encodes the 610-amino-
acid protein (67 kDa) menin. Menin acts as a tumor suppressor
through binding to DNA sequence [19], andMEN1 genewas also found
to have variable CNs in a previous CNV study [6]. In addition, miRNAs
can speciﬁcally recognize target mRNAs based on sequence comple-
mentarities that can result in translational repression or site-speciﬁc
cleavage of the targets [20]. Twenty-three miRNAs located within 15
CNVRs were identiﬁed (Supplementary Table 5), and all had been
previously reported to have variable CNs in humans.
Discussion
CNVs are widely distributed in the human genome and account for
differences in the expression of some genes [21]. Some CN-variable
genes result in phenotypic differences, and some are correlated with
human diseases [8–10]. Previous CNV discoveries were mostly limited
to HapMap samples and to samples from Caucasian individuals
[2,6,13]. There have been an increasing number of CNV survey studies
using different ethnic backgrounds [4]; however, experimental
technologies, algorithms and DNA source (e.g., DNA extracted from
cell lines versus peripheral blood) are all critical factors in identifying
reliable CNVs. Like SNPs, CNVs also show a slight variability amongpopulations; therefore, comprehensive CNV information is needed
when applying CNVs as genetic markers in disease or trait studies.
We believe that the CNVRs identiﬁed in this study are highly
reliable, because although data from only 304 of the 813 individuals
were validated using the Affymetrix 500K SNP array, all of the
validated CNVs were replicable in two independent experiments. An
assumption of the CNIT algorithm, which was used to analyze the data
of Affymetrix 500K SNP array, is that the CN value of each SNP in the
reference group should be two [16]; however, this is not always true.
Fortunately, the CNVs of HapMap individuals have been reported, so
we excluded SNPs deviating from CN=2 before constructing the CNIT
algorithm. A previous study showed that the CNIT program is a more
accurate algorithm for CN estimation of Affymetrix GeneChip data
than other programs [16], and the 500K CNIT program constructed in
this report is freely available.
In this large-scale survey of CNVs in the Han Chinese population
residing in Taiwan, the majority (81.6%) of CNVRs had been previously
reported in other populations, and 10% identiﬁed in this study were
also reported in a previous smaller-scale Han Chinese CNV survey
study [15]. The CNVs of Han Chinese residing in Taiwan share common
ancestry with the Asian population (Fig. 4), and CNVs reported in
HapMap CHB and JPT are replicable in this study (Supplementary
Fig. 2). Because PennCNV algorithm with default parameters is not
suitable to analyze CNVs from sex chromosomes, CNVRs identiﬁed in
this study are all located on the autosomal chromosomes. Some CN-
variable genes identiﬁed herewere correlatedwith diseases; however,
no phenotype data was available for the apparently normal indivi-
duals in this population-based study [22]. These individuals with CN
changes in disease-associated genes were not ascertained based on
disease status, but were randomly sampled throughout Taiwan,
indicating the copy numbers of some disease-associated genes are
polymorphic in the general population. In addition, the boundaries of
the CNVRs cannot be precisely determined using SNP arrays, so we
cannot determine whether the additional copies of the ampliﬁed
genes and their regulatory elements are complete and functional. In
contrast, CN losses can directly disrupt coding sequences and pro-
moters of genes and have even been shown to result in gene fusion in
a previous study [9].
Currently, CNV discovery and the impact of these regions on phe-
notypes and diseases are popular issues in human genomic studies. In
245C.-H. Lin et al. / Genomics 94 (2009) 241–246this study, 67 (18.4%) CNVRs were new, indicating that CNV coverage
of the human genome is still incomplete and that there is diversity
between the Han Chinese and other ethnic populations. The CNV
allele frequencies in the Han Chinese population were generally rare,
and only seven CNVRs had allele frequencies of more than 10%, which
is consistent with the results of Jakobsson et al.'s study [3]. These
newly identiﬁed CNVRs extend the coverage of CNVRs in the human
genome and should be taken into considerationwhen genetic studies,
e.g., CNV association studies, are conducted.
Materials and methods
Illumina BeadChip data
Samples from one thousand unrelated individuals were randomly
collected from the Taiwanese Cell and Genome Bank [22]. The Puregene
DNA puriﬁcation kit (Gentra Systems, Minneapolis, MN, USA) was used
to extract genomic DNA from blood. Individual genotyping was
performed using the Illumina HumanHap550-Duo BeadChip (Illumina,
San Diego, CA, USA) according to the manufacturer's instructions. The
PennCNV program is a hidden Markov model (HMM)-based algorithm
for the Illumina array that takes into consideration the total signal
intensity and allelic intensity ratio at each SNP marker, the distance
between neighboring SNPs and the allele frequency of each SNP. The
PennCNV programwas used to analyze raw data to identify CN-altered
regions, and the data of only 833 samples passed the previously
validated default quality control criteria, which exclude samples with a
log R ratio standard deviation of N0.28, a median B allele frequency of
N0.55 or b0.45 or a B allele frequency drift of N0.002 [13]. In addition,we
removed the data of eight individuals because theywere correlatedwith
others based on IBS/IBD estimation using the genotype of Illumina 550K
SNPs (Supplementary Fig. 1) [23], and also excluded the data of 12
individuals whose CNV numbers were outliers of general CNV number
distribution. First, a total of 20,257 CN-altered events were identiﬁed in
the 813 samples using the PennCNV program. Because certain factors
intrinsic to SNP array analysis are believed to affect signal intensity
readouts [13], additional criteria were necessary to eliminate false-
positive results. Only DNA segments that covered more than ten SNP
probes were regarded as true CN-altered sites [13]. Using this criterion,
4452 reliable CN-altered events (1025non-redundant genomic regions)
were found in the 813 individuals.
Affymetrix GeneChip data
Three hundred and four individuals were genotyped using the
Affymetrix 500KGeneChip HumanMapping set (Santa Clara, CA, USA)
by the National Genotyping Center (Academia Sinica, Taipei, Taiwan)
according to the manufacturer's instructions. The signal intensity data
of the Affymetrix GeneChip were analyzed using both the CNIT [16]
and CNAT 4.0 programs (Affymetrix) to predict CN-altered regions.
The details of the construction of the HMM-based CNITalgorithmhave
been reported [16]; brieﬂy, the signal intensity data of Affymetrix
500K GeneChip arrays from 270 individuals were downloaded from
the database of HapMap project, and the CNV information for these
individuals were collected [4]. These individuals included 30 Cauca-
sian trios, 30 African trios and 90 unrelated Asian individuals. The
HapMap reference group, which includes 210 multi-ethnic unrelated
individuals, was used to determine the parameters of CNIT for SNP CN
estimation. Forty offspring were organized as a training group for the
HMM method. Twenty additional offspring were used as a test group
to evaluate the FPR and FNR.
Quantitative PCR validations
qPCR experiments were performed using the ABI PRISM 7900
Sequence Detector (Applied Biosystems, Foster City, CA, USA) tovalidate genes with variable CN. Primer Express Software version 3.0
(Applied Biosystems) was used to design PCR primers for the
selected target CNVs. PCR reactions were prepared using the Power
SYBR-Green PCR reagent kit (Applied Biosystems). PCR reactions
(25 μl total) contained 2.5 ng genomic DNA for each CNV. qPCR
conditions were as follows: initial denaturation at 94 °C for 3 min,
followed by 40 cycles of denaturation at 94 °C for 15 s, and combined
annealing and extension at 60 °C for 60 s. The ﬂuorescence signals
were detected in real time during the qPCR procedure. The CN of a
target gene was determined by the relative quantitative comparative
threshold cycle (ΔΔCt) method using the long interspersed nuclear
elements 1 (LINE-1) as the endogenous control. The CN of the target
gene in test sample against reference samples is given by 2×2−ΔΔCt,
where ΔΔCt=(Ct of target gene in each test sample−Ct of LINE-1
in each test sample)−(average Ct of target gene in reference
samples−average Ct of LINE-1 in reference samples) [24]. The mean
estimated CN was calculated from triplicate PCR reactions for each
individual, and the results of target loci from samples with CNVs
were compared to the average of ﬁve reference samples with no CN
change.
Genetic and statistical analyses
In CNVs and SDs analysis, SDs are deﬁned as DNA sequences
sharing N90% sequence similarity over N1 kb with another genomic
location, and their locations are downloaded from the Human
Genome Segmental Duplication Database. Because the boundary of
CNVRs cannot be determined only based on SNP array data, we
focused on SDs which are located nearby CNV regions (less than
20 kb) [1,4]. The above data analyses and managements were per-
formed using SAS/STAT version 8 software (SAS Institute, Cary, NC,
USA). In phylogenetic tree construction, Nei's distance [25] between
any two populations was calculated based on the allele frequency of
19 polymorphic CNV regions (frequency N0.01, shared CNV regions
between Jakobsson et al.'s [3] and our studies). Although 29 po-
pulations were analyzed by using Illumina 550K BeadChip in
Jakobsson et al.'s study, only eight populations with more than 30
individuals were used in the following analysis. The neighbor-joining
approach was applied to construct the phylogenetic tree, and a
bootstrapping procedure with 10,000 replications was used to
conﬁrm the reproducibility of the resultant phylogenetic tree. The
construction of phylogenetic tree was conducted by using PHYLIP
program [25].
URLS
CNIT program (http://www.ibms.sinica.edu.tw/%7Ecsjfann/ﬁrst%
20ﬂow/programlist.htm).
Database of Genomic Variants (http://projects.tcag.ca/variation/).
HapMap project (http://www.hapmap.org/).
Gene Ontology (http://www.geneontology.org/).
Human Genome Segmental Duplication Database (http://projects.
tcag.ca/humandup/).
PLINK (http://pngu.mgh.harvard.edu/purcell/plink/).
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